Neutral effects of SGLT2 inhibitors in acute coronary syndromes, peripheral arterial occlusive disease, or ischemic stroke: a meta-analysis of randomized controlled trials

BACKGROUND: Patients with type 2 diabetes are at increased risk for cardiovascular diseases. Sodium-glucose transport 2 inhibitors (SGLT2i) have been shown to enhance cardiovascular health since their debut as a second-line therapy for diabetes. Acute coronary syndrome (ACS), peripheral arterial occ...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Pei-Chien, Chuang, Wei-Jung, Ko, Albert Min-Shan, Chen, Jui-Shuan, Chiu, Cheng-Hsun, Chen, Chun-Han, Yeh, Yung-Hsin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012509/
https://www.ncbi.nlm.nih.gov/pubmed/36915157
http://dx.doi.org/10.1186/s12933-023-01789-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012509/
https://www.ncbi.nlm.nih.gov/pubmed/36915157
http://dx.doi.org/10.1186/s12933-023-01789-5

Ejemplares similares